ASHLEY DOERLER: Open Payments
NPI 1144722398 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 28 payments from 12 companies in 2025. Trend: 2023 $287 · 2024 $0 · 2025 $734
Food & beverage: $635Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $121 |
| Galderma Laboratories, L.P. | 5 | $107 |
| ViiV Healthcare Company | 3 | $94 |
| Paratek Pharmaceuticals, Inc. | 4 | $83 |
| Amgen Inc. | 3 | $76 |
| ABBVIE INC. | 3 | $56 |
| Incyte Corporation | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Lilly USA, LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: TREMFYA, NEMLUVIO, APRETUDE, NUZYRA, OTEZLA, SKYRIZI, OPZELURA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
